When tumor cells are activated by immunotherapy, activation of CD8+ T cells and production of interferon (IFN)-γ to normalize tumor vasculature can sensitize tumors to radiation therapy through mechanisms that include normalization of the tumor vascular system and tissue hypoxia [13–15] (Fig. 1). The gene discussed is CD8A; the disease is neoplasm.